Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 2Dermatologic 2Thoracic 1Lymphoid 1Head & Neck 1Genitourinary 1Breast 1

Conditions

Carcinoma, Non-Small-Cell Lung 6870Lung Neoplasms 5102Small Cell Lung Carcinoma 1166Breast Neoplasms 855Neoplasms 762Colorectal Neoplasms 668Melanoma 566Ovarian Neoplasms 506Neoplasm Metastasis 480Pancreatic Neoplasms 472Adenocarcinoma of Lung 397Stomach Neoplasms 396Prostatic Neoplasms 370Head and Neck Neoplasms 367Carcinoma, Renal Cell 350Esophageal Neoplasms 337Squamous Cell Carcinoma of Head and Neck 325Mesothelioma, Malignant 324Colonic Neoplasms 293Mesothelioma 289Urinary Bladder Neoplasms 262Brain Neoplasms 254Uterine Cervical Neoplasms 243Triple Negative Breast Neoplasms 222Sarcoma 197Endometrial Neoplasms 196Carcinoma, Hepatocellular 186NSCLC 167Pleural Effusion, Malignant 160Kidney Neoplasms 160

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Photosensitivity Disorders × Thoracic × Clear all
NCT03992664 2025-02-13

Education Intervention in Patients with Rash Due to Epidermal Growth Factor Receptor (EGFR) Treatment.

Cyprus University of Technology

Phase NA Completed
40 enrolled
BreastGastrointestinalHead & NeckThoracic

Breast Neoplasms, Colonic Neoplasms, Exanthema, Head and Neck Neoplasms, Lung Neoplasms, Pancreatic Neoplasms, Photosensitivity Disorders, Pruritus

Data powered by HemOnc (CC BY 4.0) Colophon âš¡